Tao Chen Selected Research

Qingrejiedu

6/2016	Chinese herbal formula QHF inhibits liver cancer cell invasion and migration.
2/2008	Screening of QHF formula for effective ingredients from Chinese herbs and its anti-hepatic cell cancer effect in combination with chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tao Chen Research Topics

Disease

268	Neoplasms (Cancer) 10/2022 - 02/2002
73	Infections 12/2022 - 08/2006
51	Inflammation (Inflammations) 01/2022 - 02/2011
40	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2005
37	Carcinogenesis 10/2021 - 10/2002
30	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 03/2003
27	Pain (Aches) 01/2022 - 07/2005
26	Wounds and Injuries (Trauma) 06/2022 - 12/2004
25	Body Weight (Weight, Body) 01/2022 - 06/2004
23	Breast Neoplasms (Breast Cancer) 01/2022 - 10/2002
22	Stomach Neoplasms (Stomach Cancer) 07/2022 - 07/2008
22	Lymphoma (Lymphomas) 01/2022 - 01/2002
21	Carcinoma (Carcinomatosis) 10/2020 - 03/2006
20	Type 2 Diabetes Mellitus (MODY) 08/2021 - 10/2008
19	Insulin Resistance 04/2022 - 10/2010
18	Traumatic Brain Injuries (Traumatic Brain Injury) 03/2022 - 02/2002
18	Lung Neoplasms (Lung Cancer) 02/2022 - 05/2003
17	Atherosclerosis 01/2022 - 08/2009
17	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 02/2005
16	Necrosis 11/2022 - 08/2005
16	Stroke (Strokes) 01/2022 - 12/2010
15	Tuberculosis (Tuberculoses) 01/2022 - 10/2013
15	Hypertension (High Blood Pressure) 01/2022 - 02/2002
14	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 02/2002
14	Pancreatitis 01/2022 - 01/2014
13	Hemorrhage 05/2022 - 03/2008
13	Glioma (Gliomas) 01/2021 - 07/2009
12	Human Influenza (Influenza) 06/2022 - 10/2011
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2022 - 03/2007
12	Hypoxia (Hypoxemia) 01/2022 - 05/2014
12	Myocardial Infarction 01/2022 - 10/2010
11	Diabetes Mellitus 04/2022 - 04/2009
11	Brain Injuries (Brain Injury) 02/2022 - 02/2002
11	Hyperaldosteronism (Conn Syndrome) 01/2022 - 08/2019
11	Fibrosis (Cirrhosis) 10/2021 - 03/2015
10	COVID-19 06/2022 - 01/2020
10	Ischemic Stroke 01/2022 - 12/2010
10	Thrombosis (Thrombus) 05/2021 - 04/2008
10	Chronic Pain 01/2021 - 12/2010
10	Parkinson Disease (Parkinson's Disease) 04/2020 - 01/2013
9	Hyperglycemia 04/2022 - 11/2009
9	Adenoma (Adenomas) 01/2022 - 01/2017
9	Ischemia 01/2022 - 01/2002
9	Chronic Hepatitis B 01/2022 - 07/2003
9	Sepsis (Septicemia) 04/2021 - 07/2009
9	Neuralgia (Stump Neuralgia) 01/2021 - 01/2011
9	Liver Neoplasms (Liver Cancer) 01/2021 - 02/2008
9	Acute Lung Injury 11/2020 - 01/2010
8	Cryptococcal Meningitis 01/2022 - 01/2018

Drug/Important Bio-Agent (IBA)

83	Proteins (Proteins, Gene)FDA Link 08/2022 - 03/2004
53	Pharmaceutical PreparationsIBA 05/2022 - 04/2005
48	Biomarkers (Surrogate Marker)IBA 07/2022 - 06/2011
42	MicroRNAs (MicroRNA)IBA 01/2022 - 04/2010
36	CytokinesIBA 12/2022 - 04/2005
34	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 12/2007
28	Biological ProductsIBA 01/2022 - 05/2003
28	Messenger RNA (mRNA)IBA 01/2022 - 02/2005
24	EnzymesIBA 10/2022 - 04/2006
21	Therapeutic UsesIBA 01/2022 - 08/2005
20	DNA (Deoxyribonucleic Acid)IBA 05/2022 - 03/2002
19	Long Noncoding RNAIBA 11/2021 - 11/2015
18	Interleukin-6 (Interleukin 6)IBA 11/2022 - 04/2005
17	LipidsIBA 01/2022 - 10/2008
16	VaccinesIBA 06/2022 - 10/2011
14	AntioxidantsIBA 06/2022 - 03/2011
13	AntibodiesIBA 05/2022 - 04/2011
13	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2021 - 12/2004
12	Anti-Bacterial Agents (Antibiotics)IBA 12/2022 - 12/2014
12	Oxygen (Dioxygen)IBA 09/2022 - 02/2002
12	LigandsIBA 01/2022 - 01/2010
12	Insulin (Novolin)FDA Link 10/2019 - 03/2011
11	RNA (Ribonucleic Acid)IBA 05/2022 - 07/2009
11	Analgesics (Analgesic Drugs)IBA 04/2022 - 01/2011
11	AldosteroneIBA 01/2022 - 08/2019
11	Retinaldehyde (Retinal)IBA 01/2021 - 03/2013
11	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 02/2005
11	CarcinogensIBA 01/2017 - 01/2005
10	Antiviral Agents (Antivirals)IBA 06/2022 - 01/2015
10	CholesterolIBA 01/2022 - 06/2012
10	Interleukin-17 (Interleukin 17)IBA 11/2021 - 08/2012
10	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2020 - 10/2010
10	Peptides (Polypeptides)IBA 01/2020 - 02/2002
9	Adenosine Triphosphate (ATP)IBA 05/2022 - 08/2005
9	Neuroprotective AgentsIBA 01/2022 - 12/2010
9	AntigensIBA 01/2022 - 01/2013
9	Small Interfering RNA (siRNA)IBA 01/2021 - 05/2008
9	Ferritins (Ferritin)IBA 01/2021 - 12/2010
9	CalciumIBA 12/2019 - 03/2004
8	Circular RNAIBA 05/2022 - 01/2019
8	Indicators and Reagents (Reagents)IBA 04/2022 - 01/2014
8	Triglycerides (Triacylglycerol)IBA 01/2022 - 10/2008

Therapy/Procedure

115	Therapeutics 05/2022 - 02/2002
40	Drug Therapy (Chemotherapy) 03/2022 - 02/2005
15	Stents 01/2022 - 04/2008
10	Lasers (Laser) 12/2022 - 11/2011
10	Percutaneous Coronary Intervention 01/2022 - 10/2010
9	Immunotherapy 05/2022 - 02/2014
9	Gastrectomy 01/2022 - 08/2013
9	Aftercare (After-Treatment) 03/2021 - 11/2005
8	Length of Stay 01/2022 - 10/2010